Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baicalein tablets for influenza fever in otherwise healthy adults
ChiCTR1900020928Phase 2Not yet recruiting
- Sponsor
- Capital Medical University
- Start
- Nov 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of baicalein in influenza (3 arms), sponsored by Capital Medical University. Primary endpoint: Time to fever relief. Planned start Nov 2018; status: not yet recruiting.
02
Drugs
baicalein
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR1900020928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900020928.